IHS Chemical Week

Regions :: North America :: Canada

Mitsubishi Chemical completes acquisition of Medicago

12:05 AM MDT | September 20, 2013 | Deepti Ramesh

Mitsubishi Chemical Holdings says that its Mitsubishi Tanabe Pharma (Osaka) subsidiary has completed the previously announced acquisition of Canadian pharmaceutical company Medicago (Quebec City). Medicago will be operated as a joint venture owned 60% by Mitsubishi Tanabe Pharma and 40% by Philip Morris Investments (Bergen op Zoom, Netherlands). Medicago is a clinical-stage biopharmaceutical company that develops vaccines and therapeutic proteins to address a range of infectious diseases. Shares of Medicago were delisted from trading on the Tokyo Stock Exchange...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa